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SUMMARY. Drug-drug interaction (DDI) is a challenging problem for treatment of HIV-infected patients.
Zidovudine (AZT), prescribed under the names Retrovir and Retrovis, is the first U.S. government-ap-
proved antiretroviral drug used for the successful treatment of HIV/AIDS infectiousness. Given that gin-
seng is frequently utilized in combination with AZT and AZT is mainly eliminated by UDP-glucuronosyl-
transferase 2B7, the aim of present study is to investigate the inhibition of UGT2B7-catalyzed AZT glu-
curonidation by 20(S)-protopanaxatriol type (Ppt) which is the main ginsenoside absorbed into the plas-
ma. The results showed that ppt competitively inhibited UGT2B7-catalyzed AZT glucuronidation, and the
inhibition kinetic parameter (Ki) was determined to be 24.7 μM. Using the maximum plasma concentra-
tion of ppt (Cmax), the alteration of area under the curve (AUC) of AZT was 6 %. All these results provide
important information for understanding ginseng-AZT interaction. However, considering the complica-
tion of herbs and individuals, the in vitro-in vivo extrapolation (IV-IVE) results should be explained with
more caution.
